UKHSA data dashboard

The UKHSA data dashboard shares public health data in a simple, inclusive and accessible way. The dashboard covers a range of topics such as respiratory viruses, healthcare-associated infections and antimicrobial resistance that inform public health decision making in England.

Health topics

Antimicrobial consumption

Rate of total antibiotic consumption

Antibiotic use by month (Defined Daily Doses per 1,000 inhabitants per day (DID))

There is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for antibiotics. Specifically the metric 'antibiotics_consumption_totalDID' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 31 December 2018 to 31 December 2025. It fell from 18.27 on 31 December 2018 to 18.13 on 29 February 2020. It fell from 18.49 on 31 March 2020 to 14.69 on 30 April 2021. It rose from 14.0 on 31 May 2021 to 16.23 on 30 June 2022. It fell from 15.79 on 31 July 2022 to 15.71 on 31 August 2023. It rose from 15.73 on 30 September 2023 to 16.9 on 31 October 2024. And finally. It rose from 16.96 on 30 November 2024 to 17.73 on 31 December 2025. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.

Daily total antibiotic use in England, per 1,000 inhabitantsVisit Rate of total antibiotic consumption to find out more

Rate of primary care antibiotic consumption

Antibiotic use by month (Defined Daily Doses per 1,000 inhabitants per day (DID))

Daily antibiotic use in England in primary care settings, per 1,000 inhabitantsVisit Rate of primary care antibiotic consumption to find out more

Rate of secondary care antibiotic consumption

Antibiotic use by month (Defined Daily Doses per 1,000 inhabitants per day (DID))

Daily antibiotic use in England in secondary care settings, per 1,000 inhabitantsVisit Rate of secondary care antibiotic consumption to find out more

Antimicrobial resistance (AMR)

Glycopeptide resistance in E. faecium

Rolling percentage of resistant samples by month

Monthly proportion of E. faecium isolates from blood samples in England which show resistance to glycopeptidesVisit Glycopeptide resistance in E. faecium to find out more

Carbapenem resistance in K. pneumoniae

Rolling percentage of resistant samples by month

Monthly proportion of K. pneumoniae isolates from blood samples in England which show resistance to carbapenemsVisit Carbapenem resistance in K. pneumoniae to find out more

Third-generation cephalosporin resistance in E. coli

Rolling percentage of resistant samples by month

Monthly percentage of E. coli isolates from blood samples in England which show resistance to third generation cephalosporinsVisit Third-generation cephalosporin resistance in E. coli to find out more

Blood-borne viruses

Hepatitis B

Mortality rate per 100,000 population

Annual hepatitis B mortality rate in EnglandVisit Hepatitis B to find out more

Hepatitis C

Estimated prevalence in general population by year

Annual hepatitis C prevalence in the general population in EnglandVisit Hepatitis C to find out more

HIV

New diagnoses per 100,000 population

Annual rate of new HIV diagnoses per 100,000 populationVisit HIV to find out more

Childhood vaccinations

MMR1

Coverage in children aged 24 months by year

Annual percentage uptake of the first measles, mumps and rubella vaccination by age 2 in the United KingdomVisit MMR1 to find out more

6-in-1 (DTaP/IPV/Hib3/HepB) vaccine coverage in the UK

Coverage in children aged 12 months by year

Annual percentage uptake of the ‘6-in-1’ vaccination by 12 months in the United KingdomVisit 6-in-1 (DTaP/IPV/Hib3/HepB) vaccine coverage in the UK to find out more

Emerging infections and zoonoses

Mpox Ib

Cases by month

Monthly mpox clade Ib case countsVisit Mpox Ib to find out more

Mpox IIb

Cases by month

Monthly mpox clade IIb case countsVisit Mpox IIb to find out more

Environmental hazards

Lead

Cases by year (note: case definition updated in 2021)

Number of lead cases identified each year among children in EnglandVisit Lead to find out more

Gastrointestinal infections

Norovirus

Weekly laboratory reports

Weekly lab-confirmed cases of norovirus infection in EnglandVisit Norovirus to find out more

Healthcare-associated infections (HCAI)

Escherichia coli (E. coli)

Bloodstream infections by month

Monthly counts of E. coli bacteraemia infections in the blood in EnglandVisit Escherichia coli (E. coli) to find out more

Clostridioides difficile (C. difficile)

Infections by month

Monthly counts of C. difficile bacteraemia infections in EnglandVisit Clostridioides difficile (C. difficile) to find out more

Klebsiella species (Klebsiella spp.)

Infections by month

Monthly counts of Klebsiella spp bacteraemia infections in the blood in EnglandVisit Klebsiella species (Klebsiella spp.) to find out more

Meticillin-resistant Staphylococcus aureus (MRSA)

Bloodstream infections by month

Monthly counts of MRSA bacteraemia infections in the blood in EnglandVisit Meticillin-resistant Staphylococcus aureus (MRSA) to find out more

Meticillin-susceptible Staphylococcus aureus (MSSA)

Bloodstream infections by month

Monthly counts of MSSA bacteraemia infections in the blood in EnglandVisit Meticillin-susceptible Staphylococcus aureus (MSSA) to find out more

Pseudomonas aeruginosa (P. aeruginosa)

Bloodstream infections by month

Monthly counts of P. aeruginosa infections in the blood in EnglandVisit Pseudomonas aeruginosa (P. aeruginosa) to find out more

Outbreaks

Measles

Cases by week of symptom onset

Weekly count of measles cases in EnglandVisit Measles to find out more

Respiratory bacteria

Mycoplasma pneumoniae

Testing positivity

The number of monthly positive tests in England.Visit Mycoplasma pneumoniae to find out more

Respiratory viruses

Influenza

Testing positivity

Weekly percentage of people tested by PCR who are positive for influenza in EnglandVisit Influenza to find out more

COVID-19

Testing positivity

Weekly percentage of people tested by PCR who are positive for COVID-19 in EnglandVisit COVID-19 to find out more

Respiratory syncytial virus (RSV)

Testing positivity

Weekly percentage of people tested by PCR who are positive for respiratory syncytial virus in EnglandVisit Respiratory syncytial virus (RSV) to find out more

Adenovirus

Testing positivity

Weekly percentage of people tested by PCR who are positive for adenovirus in EnglandVisit Adenovirus to find out more

Human metapneumovirus (hMPV)

Testing positivity

Weekly percentage of people tested by PCR who are positive for human metapneumovirus in EnglandVisit Human metapneumovirus (hMPV) to find out more

Parainfluenza

Testing positivity

Weekly percentage of people tested by PCR who are positive for parainfluenza in EnglandVisit Parainfluenza to find out more

Rhinovirus

Testing positivity

Weekly percentage of people tested by PCR who are positive for rhinovirus in EnglandVisit Rhinovirus to find out more

Streptococcal infections

Invasive group A streptococcal infection (iGAS)

Laboratory notifications by week

Weekly lab‑confirmed cases of Invasive group A strep (iGAS) infection in EnglandVisit Invasive group A streptococcal infection (iGAS) to find out more

Scarlet fever

GP consultation rate

Weekly GP in-hours consultation rates for scarlet fever in England, per 100,000 registered patientsVisit Scarlet fever to find out more

Syndromic surveillance

Acute respiratory infections

From the NHS 111 remote health advice syndromic surveillance system

Count of daily, triaged calls to the NHS 111 remote health system in England for acute respiratory infectionsVisit Acute respiratory infections to find out more

Upper respiratory tract infections

From the GP in-hours syndromic surveillance system

Daily consultation rate of GP-in hours attendances in England for upper respiratory tract infectionsVisit Upper respiratory tract infections to find out more